Inventor
NAM DO-HYUN
KR32 patents
⚠️ This page may combine multiple inventors who share the name “NAM DO-HYUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
13 patentsUS10364289B2Jul 30, 2019
Antibody binding to neuropilin 1 and use thereof
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION2 citations71
US9296817B2Mar 29, 2016
Antibodies cross-reactive to human and mouse c-Met and uses thereof
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION5 citations68
US9750826B2Sep 5, 2017
Method for preparing patient-specific glioblastoma animal model, and uses thereof
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION2 citations65
US11199536B2Dec 14, 2021
Method for screening antibody using patient-derived tumor spheroids
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION0 citations52
US11085930B2Aug 10, 2021
Anti-NRP1 antibody screening method
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION0 citations52
US10669340B2Jun 2, 2020
Antibody against EGFRvIII and use thereof
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION0 citations51
US9587280B2Mar 7, 2017
Method for detecting a c-Met gene using cleavable probe
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION1 citations50
US9512488B2Dec 6, 2016
Method for multiplex-detecting chronic myelogenous leukemia gene using cleavable probe
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION0 citations50
US10640777B2May 5, 2020
Antibody to human and mouse SEMA3A and use thereof
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION0 citations48
US10604571B2Mar 31, 2020
Antibody to human and mouse SEMA3A and use thereof
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION0 citations48
US10604572B2Mar 31, 2020
Antibody to human and mouse Sema3A and use thereof
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION0 citations48
US9493739B2Nov 15, 2016
Composition for proliferating stem cells by activating notch signaling
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION1 citations46
US9562891B2Feb 7, 2017
Method for screening patient-specific anti-cancer agent using limiting dilution assay
SAMSUNG LIFE PUBLIC WELFARE FOUNDATION1 citations44
LG CHEMICAL LTD
6 patentsUS5962468AOct 5, 1999
7-(4-aminomethyl-3-methyloxyiminopyrrolidin-1-yl)-1- cyclopropyl-6-fluoro-4-oxo-1, 4-dihydro-1, 8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
LG CHEMICAL LTD30 citations95
US5869670AFeb 9, 1999
7-(4-aminomethyl-3-methyloxyiminopyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
LG CHEMICAL LTD46 citations95
US5776944AJul 7, 1998
7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
LG CHEMICAL LTD38 citations92
US5840916ANov 24, 1998
Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituent and processes for preparing thereof
LG CHEMICAL LTD7 citations72
US5698570ADec 16, 1997
Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime)pyrrolidine substituent and processes for preparing thereof
LG CHEMICAL LTD7 citations70
US6284912B1Sep 4, 2001
Process for synthesizing para-and/or meta-substituted cyanophenyalanine derivatives
LG CHEMICAL LTD2 citations61
LG LIFE SCIENCES LTD
3 patentsUS6723734B2Apr 20, 2004
Salt of naphthyridine carboxylic acid derivative
LG LIFE SCIENCES LTD16 citations83
US7700617B2Apr 20, 2010
Salt of naphthyridine carboxylic acid derivative
LG LIFE SCIENCES LTD2 citations61
US7361762B2Apr 22, 2008
Process for preparing acid salts of Gemifloxacin
LG LIFE SCIENCES LTD0 citations37
AIMED BIO INC
3 patentsUS11576896B2Feb 14, 2023
Benzoselenophene-based compounds, pharmaceutical compositions and antibody-drug conjugates including the same
AIMED BIO INC2 citations65
US11938115B2Mar 26, 2024
Benzoselenophene-based compound, pharmaceutical composition containing same, and antibody-drug conjugate
AIMED BIO INC0 citations55
US11591718B2Feb 28, 2023
Magnetic-based biopanning method through attachment of magnetic bead to cell
AIMED BIO INC0 citations38